Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00542490 · ClinicalTrials.gov registry record · Phase 2
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer
A Phase 2 study, sponsored by University of Oklahoma.
- Completed
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
NCT00542490 is a Phase 2 study that has completed, run by University of Oklahoma. The registered enrollment target is 23 participants.
The verdict
NCT00542490, a Phase 2 study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the progression-free survival of patients with surgically staged, Stage I-II papillary serous, clear cell, or endometrioid carcinomas with high-intermediate risk factors treated by vaginal cuff brachytherapy followed by chemotherapy.
Interventions
- RADIATION Vaginal Cuff Brachytherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-09 |
| Est. Completion | 2016-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00542490
The ClinicalTrials.gov registry entry for NCT00542490 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vaginal Cuff Brachytherapy is the first listed.
NCT00542490 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00542490 about?
NCT00542490 is a clinical study titled "Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer". The purpose of this study is to determine the progression-free survival of patients with surgically staged, Stage I-II papillary serous, clear cell, or endometrioid carcinomas with high-intermediate risk factors treated by vaginal cuff brachytherapy followed by chemotherapy.
What is the current status of trial NCT00542490?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2007-09. Estimated completion is 2016-02.
What interventions are being tested in trial NCT00542490?
The interventions under investigation include: Vaginal Cuff Brachytherapy (RADIATION).
Who is sponsoring clinical trial NCT00542490?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.